Clinical Applications of Gemcitabine in the Treatment of Refractory Non-Hodgkin s Lymphoma

Objective To study the effects of gemcitabine combined with cisplatine and predinisone in the treatment of refractory Non-Hodgkin s Lymphoma(NHL). Methods 10 patients with refractory NHL were treated with gemcitabine, 1000mg/m 2,VD,d_ 1,8;cisplatine, 25mg/m 2,VD,d_ 1～3; and prednisone, 60mg/m 2, po,d_ 1～5; every cycle(3～4 weeks). All patients received at least three cycles of chemotherapy. Results There were 2 cases of CR, 5 cases of PR and the total response rate was 70%. Of the 4 patients who suffe...